fenbufen has been researched along with Anemia, Hemolytic in 2 studies
fenbufen: structure; RN given refers to parent cpd
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beucler, A | 1 |
| Rezeau, H | 1 |
| Castot, A | 1 |
| Guillemain, JL | 1 |
| Angellier, JF | 1 |
| Martland, T | 1 |
| Stone, WD | 1 |
2 other studies available for fenbufen and Anemia, Hemolytic
| Article | Year |
|---|---|
[Hemolytic anemia caused by fenbufen].
Topics: Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Humans; Male; Middle Aged; Phenylbutyrat | 1986 |
Haemolytic anaemia associated with fenbufen.
Topics: Aged; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Humans; Male; Phenylbutyrates | 1988 |